As of Friday close, Outset Medical Inc.’s (NASDAQ:OM) stock was up $0.29, moving up 2.08 percent to $14.22. The average number of shares traded per day over the past five days has been 443,140 shares. 1 time new highs have been achieved over the past 5 days, with a -$1.82 fall in that time frame. In the last twenty days, the average volume was 575,445, while in the previous 50 days, it was 488,014.
Since last month, OM stock retreated -25.30%. Shares of the company fell to $13.55 on 08/18/23, the lowest level in the past month. A 52-week high of $30.55 was reached on 02/03/23 after having rallying from a 52-week low of $11.41. Since the beginning of this year, OM’s stock price has dropped by -44.93% or -$11.60, and marked a new high 8 times. However, the stock has declined by -53.45% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
OM stock investors should be aware that Outset Medical Inc. (OM) stock had its last reported insider trading activity 3 days ago on Aug 16. Trigg Leslie, the Chair and CEO of the company, disposed of 3,028 shares for $15.10 on Aug 16. It resulted in a $45,723 divestment by the insider. Ahmed Nabeel sold 1,565 shares at an average price of $15.10 on Aug 16. The insider now owns 89,171 shares following the transaction. On Aug 16, General Counsel Brottem John L. sold 1,364 shares at $15.10 apiece. The transaction was valued at $20,596.
Valuation Metrics
The stock’s beta is 1.58. Besides these, the trailing price-to-sales (P/S) ratio of 5.44, the price-to-book (PB) ratio of 3.80.
Financial Health
In the three months ended June 29, Outset Medical Inc.’s quick ratio stood at 5.40, while its current ratio was 6.30, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.53, and the total debt-to-equity ratio was 0.53. On the profitability front, the trailing twelve-month gross margin is 18.40% percent. Based on annual data, OM earned $17.83 million in gross profit and brought in $115.38 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -47.50%. Return on equity (ROE) for the past 12 months was -73.70%.
In Outset Medical Inc.’s quarter-end financial report for June 29, it reported total debt of $96.63 million against cash and short-term investments of $186.4 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. OM’s revenue rose 29.8% to $33.47 million during the quarter, while net income inched up to $35.7 million. While analysts expected Outset Medical Inc. to report -$0.78 quarterly earnings, the actual figure was -$0.9 per share, beating the consensus estimate by -15.40%. During the quarter, the company generated -$43.77 million in EBITDA. The liabilities of Outset Medical Inc. were 151.33 million at the end of its most recent quarter ended June 29, and its total debt was $103.41 million. The value of shareholders’ equity is $49.79 million.
Technical Picture
This quick technical analysis looks at Outset Medical Inc.’s (OM) price momentum. With a historical volatility rate of 35.65%, the RSI 9-day stood at 19.28% on 18 August.
With respect to its five-day moving average, the current Outset Medical Inc. price is down by -11.35% percent or -$1.82. At present, OM shares trade -26.28% below its 20-day simple moving average and -25.78% percent below its 100-day simple moving average. However, the stock is currently trading approximately -38.09% below its SMA50 and -8.49% below its SMA200.
Stochastic coefficient K was 3.35% and Stochastic coefficient D was 3.53%, while ATR was 0.89. Given the Stochastic reading of 9.40% for the 14-day period, the RSI (14) reading has been calculated as 23.59%. As of today, the MACD Oscillator reading stands at -1.16, while the 14-day reading stands at -2.14.
Analyst Ratings
CL King launched its rating on Outset Medical Inc. (NASDAQ: OM) to a Neutral in a note to investors on August 17, 2023. Outset Medical Inc. (OM) has been rated Overweight by analysts. According to 0 brokerage firms, OM is a sell, and 3 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Outset Medical Inc. stock as buy, with 4 recommending it as overweight.
With a median target price of $29.00, the current consensus forecast for the stock is $22.00 – $32.00. Based on these forecasts, analysts predict Outset Medical Inc. (OM) will achieve an average price target of $28.20.
